Skip to main content
Convatec Group PLC logo

Convatec Group PLC — Investor Relations & Filings

Ticker · CTEC ISIN · GB00BD3VFW73 LEI · 213800LS272L4FIDOH92 IL Manufacturing
Filings indexed 480 across all filing types
Latest filing 2023-05-17 Major Shareholding Noti…
Country GB United Kingdom
Listing IL CTEC

About Convatec Group PLC

https://www.convatecgroup.com/

Convatec is a global medical products and technologies company focused on developing and marketing solutions for the management of chronic conditions. The company holds leading market positions in its four core franchises: Advanced Wound Care, which includes products for acute and chronic wounds; Ostomy Care, providing devices for people with stomas; Continence and Critical Care, offering solutions for bladder and bowel management; and Infusion Care, which supplies devices for subcutaneous drug delivery, primarily for insulin-dependent diabetes. Its products are designed to improve patient outcomes, prevent infection, protect at-risk skin, and reduce the total cost of care for healthcare providers and patients globally.

Recent filings

Filing Released Lang Actions
Convatec Group PLC: TR1 - Notification of Major Holdings
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and details an 'acquisition or disposal of financial instruments' by BlackRock, Inc., crossing a voting rights threshold. This type of mandatory disclosure regarding changes in significant share ownership is classified as a Major Shareholding Notification. The corresponding code is MRQ.
2023-05-17 English
Convatec Group PLC: Scrip Dividend - Total Issued Shares
Share Issue/Capital Change Classification · 1% confidence The document announces the issuance of new ordinary shares resulting from a Scrip Dividend election following the proposed final dividend for the year ended December 31, 2022. The key outcome is the calculation of the new total issued share capital (2,045,589,597 ordinary shares). This directly relates to a change in the company's capital structure due to the issuance of new shares, which aligns best with the 'Share Issue/Capital Change' definition (SHA). Although it involves a dividend (DIV), the primary focus and regulatory impact reported here is the resulting share issuance and capital update, not just the dividend amount itself. It is not a general regulatory filing (RNS) because it fits a more specific category.
2023-05-09 English
Convatec Group PLC: Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document explicitly details transactions involving shares held by a Person Discharging Managerial Responsibilities (PDMR), specifically the CEO, Karim Bitar. It covers the vesting of an LTIP award and the subsequent sale of a portion of those shares to cover tax liabilities. This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing'. The filing code for this is DIRS.
2023-05-03 English
Convatec Group PLC: HOL-Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is a 'TR-1: Standard form for notification of major holdings' concerning BlackRock, Inc. crossing a threshold in Convatec Group PLC's voting rights. This type of filing reports changes in significant share ownership. Reviewing the definitions, 'Major Shareholding Notification' corresponds to the code 'MRQ'. The document explicitly mentions 'OAM Categories: 2.3. Major shareholding notifications' and details the resulting situation of voting rights held by a major shareholder.
2023-04-26 English
Convatec secures a highly innovative tech platform
M&A Activity Classification · 1% confidence The document begins with 'RNS Number : 6609W' and is dated April 19, 2023, indicating it is a regulatory announcement disseminated via the RNS service of the London Stock Exchange. The content details the acquisition of an anti-infective technology platform by Convatec Group PLC, including financial consideration (£45 million initial payment plus potential milestones). This type of corporate action announcement (acquisition) is typically classified as a general regulatory filing or announcement that doesn't fit into the more specific categories like Earnings Release (ER) or Capital Change (SHA). Since it is a formal announcement released through the RNS system and concerns a significant corporate transaction (M&A activity, though not a takeover bid), the most appropriate general category is Regulatory Filings (RNS), as it is a standard market disclosure. While it relates to M&A (TAR), TAR is defined as 'Merger proposals or takeover bids'. An acquisition announcement is often categorized under RNS if a more specific M&A code isn't available for general acquisitions, or if it's a standard disclosure. Given the structure and the explicit mention of RNS distribution, RNS is the safest classification, although TAR is a close secondary possibility. However, RNS serves as the general regulatory announcement fallback.
2023-04-19 English
Convatec Group PLC: Scrip Dividend - Calculation Price
Notice of Dividend Amount Classification · 1% confidence The document explicitly discusses the proposal of a final dividend, the mechanics of a scrip dividend (allowing shareholders to receive new shares instead of cash), the calculation price for those new shares, and provides a detailed timetable for dividend-related actions (Record Date, Ex-dividend Date, Payment Date). The metadata section also contains 'Category Code: DIV'. This content directly relates to the announcement of dividend amounts and details, fitting the definition for 'Notice of Dividend Amount'. Although it mentions the AGM, the primary focus is the dividend mechanics, not the AGM materials themselves.
2023-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.